Medical Science Liaison

About Quetzal Therapeutics LLC
Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also developing a pre-clinical asset QTX-2102, an advanced, next-generation antifungal and antiparasitic therapy designed to enhance efficacy while minimizing toxicity. Our mission is to push the boundaries of treatment possibilities, delivering hope and life-changing solutions to those who need them most.
Contractor Medical Science Liaison (MSL) – Italy/Germany Territory
Haematology / Oncology – Phase 3 Clinical Trial Support
Role Overview
We are seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology clinical trial across Italy and Germany. This field-based role will focus on scientific engagement with investigators and treatment centres, supporting trial awareness, operational engagement, and high-quality scientific exchange within a compliant framework.
The successful candidate will work independently across a geographically distributed territory and act as a key scientific interface between the company and external stakeholders.
Territory Coverage
Primary Territories
Italy
Germany
Travel within the assigned territory and attendance at relevant scientific meetings/congresses will be required.
Time in Field
Approximately 70–80% field-focused activity expected.
Key Responsibilities
Develop and maintain scientific relationships with investigators, referral centres, and relevant healthcare professionals
Support scientific engagement around an ongoing Phase 3 haematology clinical trial
Deliver high-quality, non-promotional scientific exchange in compliance with applicable regulations and company SOPs
Support trial awareness and operational engagement activities within assigned territories
Identify and communicate field insights, including recruitment challenges, treatment landscape developments, and investigator feedback
Support congress activities, investigator meetings, and scientific discussions as required
Ensure timely and accurate documentation of activities and reporting of adverse events/product complaints in accordance with pharmacovigilance requirements
Work cross-functionally with Medical Affairs, Clinical Operations, and other internal stakeholders
Required Qualifications & Experience
Advanced scientific or healthcare degree (PharmD, PhD, MD, MSc or equivalent)
Prior experience as a field-based MSL within oncology or haematology
Strong scientific acumen and ability to communicate complex clinical data effectively
Demonstrated ability to work independently across a multi-site territory
Experience developing relationships with academic investigators and healthcare professionals
Strong communication, presentation, and stakeholder engagement skills
Experience working within GCP, pharmacovigilance, and compliance frameworks
Fluent English
Experience within Italy and/or Germany is essential
Strongly Preferred
Italian language proficiency strongly preferred
Prior experience in haematology and/or rare cancers
Experience supporting Phase 2 or Phase 3 clinical trials
Experience supporting recruitment or referral engagement activities for clinical trials
Existing relationships within relevant haematology treatment centres
Experience working in multinational European territories
Working Model
Contractor / consultancy engagement
Field-based role
Travel required across assigned territories

Work arrangement
Yes